Authors: Victor Weigman, Ph.D. & Patrice Hugo, Ph.D.
With advancements in clinical informatics and genomics, there has been a paradigm shift from “one drug fits all” toward precision medicine – taking account of individual variability in genes, environment and lifestyle – across therapeutic areas. Precision medicine allows identification of patients who would likely benefit the most from a treatment and suffer the least side effects. For instance, such screening can reveal genetic makeup likely aligned with the molecular mechanisms of action of a drug, increasing the probability of a patient’s response to the therapy. This helps find better matches for existing and novel drugs, with the goal of ensuring that the right drug is used in the right patient at the right time.
To read more, access this whitepaper.
Related Services:
In this episode, Megan McCausland, Scientific Advisor for Flow Cytometry at Q2 Solutions, and Scott Bornheimer, Associate Director of Medical and Scientific Affairs at BD Biosciences, discuss the...
In this episode, the second of a three-part series, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage...
Author:Patrick Hurban, Ph.D., Global Head, Senior Director, Translational Genomics, Q2 Solutions Choosing the right genomic assays from a wealth of potential options stands as one of the most...